Mar-06 -

Lung cancer Group

EORTC 08983 – Phase III study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma.

EORTC found that combination treatment of cisplatin plus raltitrexed improved overall survival without affecting health-related quality of life in patients with Malignant Pleural Mesothelioma (cancer of the lining of the lungs, known as the pleura).


Go to Top